agilon health (NYSE:AGL) Coverage Initiated by Analysts at Macquarie

Macquarie started coverage on shares of agilon health (NYSE:AGL) in a report published on Monday, MarketBeat Ratings reports. The firm issued a neutral rating and a $3.00 target price on the stock.

A number of other research analysts have also recently issued reports on AGL. Evercore ISI dropped their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a report on Tuesday, October 8th. Stifel Nicolaus cut their target price on shares of agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a research note on Tuesday, November 12th. Sanford C. Bernstein assumed coverage on agilon health in a research note on Wednesday, December 11th. They issued a “market perform” rating and a $2.50 price target on the stock. Barclays dropped their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research note on Monday, November 11th. Finally, JMP Securities cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Three equities research analysts have rated the stock with a sell rating, sixteen have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, agilon health currently has an average rating of “Hold” and an average price target of $4.28.

agilon health Price Performance

Shares of NYSE AGL opened at $2.20 on Monday. The stock has a 50 day moving average of $2.42 and a two-hundred day moving average of $4.35. agilon health has a twelve month low of $1.50 and a twelve month high of $13.45. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a market cap of $904.38 million, a P/E ratio of -2.34 and a beta of 0.51.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same quarter last year, the firm earned ($0.06) EPS. On average, research analysts forecast that agilon health will post -0.52 earnings per share for the current year.

Insider Buying and Selling at agilon health

In related news, Director Diana Mckenzie acquired 12,500 shares of agilon health stock in a transaction that occurred on Monday, November 25th. The stock was acquired at an average price of $2.28 per share, with a total value of $28,500.00. Following the completion of the acquisition, the director now directly owns 51,319 shares of the company’s stock, valued at $117,007.32. This trade represents a 32.20 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John William Wulf bought 45,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 5th. The stock was bought at an average price of $2.18 per share, with a total value of $98,100.00. Following the transaction, the director now directly owns 206,133 shares in the company, valued at $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 90,000 shares of company stock worth $198,100 in the last ninety days. 3.20% of the stock is owned by insiders.

Institutional Trading of agilon health

A number of institutional investors have recently made changes to their positions in the stock. Citigroup Inc. raised its stake in shares of agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares in the last quarter. AQR Capital Management LLC grew its holdings in agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares during the period. Quantbot Technologies LP bought a new stake in agilon health in the third quarter worth about $1,742,000. Susquehanna Fundamental Investments LLC lifted its holdings in agilon health by 65.0% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock valued at $5,262,000 after acquiring an additional 316,856 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of agilon health during the 2nd quarter valued at about $1,849,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.